Arcellx (ACLX) Retained Earnings (2021 - 2025)
Arcellx's (ACLX) quarterly Retained Earnings came in at $843000.0 in Q4 2025, down 0.59% year-on-year from $848000.0 in Q4 2024, and up 100.13% quarter-over-quarter from -$667.6 million in Q3 2025.
Arcellx (ACLX) Retained Earnings (2021 - 2025) Analysis & Trends
Arcellx's Retained Earnings history runs 5 years deep, the most recent figure standing at $843000.0 for Q4 2025.
- On a quarterly basis, Retained Earnings fell 0.59% year-over-year to $843000.0 in Q4 2025; TTM through Dec 2025 was $843000.0, a 0.59% decrease from a year earlier, with the FY2025 full-year figure at $843000.0, down 0.59% from the prior year.
- Retained Earnings climbed to $843000.0 in Q4 2025 per ACLX's latest filing, from -$667.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at $911.8 million in Q2 2024 and bottomed at -$667.6 million in Q3 2025.
- The 5-year median for Retained Earnings is $403000.0 (2025), against an average of $101.0 million.
- Across the five-year window, Retained Earnings soared 2619705.0% in 2022 and tumbled 786490.91% in 2023, its largest moves.
- Year by year, Retained Earnings stood at -$20000.0 in 2021, then surged by 2619705.0% to $523.9 million in 2022, then soared by 66.87% to $874.3 million in 2023, then sank by 99.9% to $848000.0 in 2024, then fell by 0.59% to $843000.0 in 2025.
- Per Business Quant, the three latest ACLX Retained Earnings figures stand at $843000.0 (Q4 2025), -$667.6 million (Q3 2025), and $403000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 843,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | -667.65 Mn |
| Jun 30, 2025 | 403,000.00 |
| Mar 31, 2025 | 649,000.00 |
| Dec 31, 2024 | 848,000.00 |
| Sep 30, 2024 | -449.75 Mn |
| Jun 30, 2024 | 911.78 Mn |
| Mar 31, 2024 | 893.71 Mn |
| Dec 31, 2023 | 874.26 Mn |
| Sep 30, 2023 | -409.30 Mn |
| Jun 30, 2023 | 663.61 Mn |
| Mar 31, 2023 | -346.10 Mn |
| Dec 31, 2022 | 523.92 Mn |
| Sep 30, 2022 | -279.80 Mn |
| Jun 30, 2022 | -262,000.00 |
| Mar 31, 2022 | -44,000.00 |
| Dec 31, 2021 | -20,000.00 |